Research results of the studies completed so far show substantial improvement in the rate of progression of the ALSFRS-R (Amyotrophic Lateral Sclerosis Functional Rating Scale ratio, which is a predictor for the progression of ALS) score and FVC (Forced Vital capacity, represents the proportion of a person’s vital capacity that they are able to expire in the first second of forced expiration) for the six months after treatment compared to the three month run-in period.

To read the BrainStorm article, please click here.